Showing results (121-130 of 584) with videos related to

Sort By:
Pageof 59
Cancers|July 9, 2022
Radon and Lung Cancer: Current Trends and Future PerspectivesMariona Riudavets, Marta Garcia de Herreros, Benjamin Besse, et al.
Cancer Treatment Reviews|September 11, 2017
Immunosenescence and immunecheckpoint inhibitors in non-small cell lung cancer patients: Does age really matter?Roberto Ferrara, Laura Mezquita, Edouard Auclin, et al.
International Journal of Clinical Pharmacy|May 11, 2018
Olanzapine as antiemetic drug in oncology: a retrospective study in non-responders to standard antiemetic therapyFlorian Slimano, Florence Netzer, Isabelle Borget, et al.
Bulletin Du Cancer|April 5, 2011
[DNA repair pathways and non-small cell lung cancer: clinical perspectives]Ken André Olaussen, David Planchard, Julien Adam, et al.
Plos One|June 12, 2020
Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assayJordi Remon, Aurelie Swalduz, David Planchard, et al.
Clinical Lung Cancer|June 6, 2022
Clinical Utility and Outcomes Impact of Crystal Digital PCR of Sensitizing and Resistance EGFR Mutations in Patients With Advanced Non-Small Cell Lung CancerMariona Riudavets, Virginie Lamberts, Damien Vasseur, et al.
Journal for Immunotherapy of Cancer|November 29, 2024
Antecedent viral immunization and efficacy of immune checkpoint blockade: an extensive serum antibody profile to predict outcomes in non-small cell lung cancerFilippo G Dall'Olio, Wael Salem Zrafi, Quentin Blampey, et al.
Seminars in Oncology|December 10, 2009
Differential expression of biomarkers in men and womenDavid Planchard, Yohann Loriot, Aicha Goubar, et al.
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Prognostic value of HLA-A2 status in advanced non-small cell lung cancer patientsLaura Mezquita, Melinda Charrier, Laura Faivre, et al.
Critical Reviews in Oncology/Hematology|May 5, 2025
Evolving treatment for advanced non-small cell lung cancer harbouring common EGFR activating mutationsIgor Gomez-Randulfe, Federico Monaca, David Planchard, et al.
Pageof 59